NO970427L - Fremgangsmåte for fremstilling av antimikrobielle forbindelser - Google Patents
Fremgangsmåte for fremstilling av antimikrobielle forbindelserInfo
- Publication number
- NO970427L NO970427L NO970427A NO970427A NO970427L NO 970427 L NO970427 L NO 970427L NO 970427 A NO970427 A NO 970427A NO 970427 A NO970427 A NO 970427A NO 970427 L NO970427 L NO 970427L
- Authority
- NO
- Norway
- Prior art keywords
- salt
- lactam
- solvate
- preparation
- antimicrobials
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D463/12—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals attached in position 7
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
- C07D463/16—Nitrogen atoms
- C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
- C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
- C07D463/16—Nitrogen atoms
- C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
- C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D463/22—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Cephalosporin Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Quinoline Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28496094A | 1994-08-02 | 1994-08-02 | |
| PCT/US1995/009647 WO1996004247A1 (en) | 1994-08-02 | 1995-08-01 | Process for making antimicrobial compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO970427D0 NO970427D0 (no) | 1997-01-31 |
| NO970427L true NO970427L (no) | 1997-03-26 |
| NO311356B1 NO311356B1 (no) | 2001-11-19 |
Family
ID=23092187
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO19970427A NO311356B1 (no) | 1994-08-02 | 1997-01-31 | Fremgangsmåte for fremstilling av antimikrobielle forbindelser |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US5703231A (no) |
| EP (1) | EP0775114B1 (no) |
| JP (1) | JPH10504815A (no) |
| KR (1) | KR100242355B1 (no) |
| CN (1) | CN1158120A (no) |
| AT (1) | ATE190972T1 (no) |
| AU (1) | AU705818B2 (no) |
| BR (1) | BR9508514A (no) |
| CA (1) | CA2196538C (no) |
| DE (1) | DE69515882T2 (no) |
| DK (1) | DK0775114T3 (no) |
| ES (1) | ES2143644T3 (no) |
| FI (1) | FI970427A7 (no) |
| GR (1) | GR3033001T3 (no) |
| MX (1) | MX9700871A (no) |
| NO (1) | NO311356B1 (no) |
| NZ (1) | NZ290721A (no) |
| PT (1) | PT775114E (no) |
| WO (1) | WO1996004247A1 (no) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE222906T1 (de) * | 1995-09-22 | 2002-09-15 | Wakunaga Pharma Co Ltd | Pyridoncarbonsäurederivate als antibakterielle wirkstoffe |
| US6441182B1 (en) | 1999-06-10 | 2002-08-27 | Bayer Aktiengesellschaft | Method for the production of 2,6-dichloro-5-fluoro-nicotinic acid and coarse and particularly pure 2,6-dichloro-5-fluoro-nicotinic acid |
| CN1338455A (zh) * | 2000-08-16 | 2002-03-06 | 大连绿源实业有限公司 | 新的喹诺酮羧酸的制备方法 |
| AU2002229057B2 (en) * | 2000-12-14 | 2005-04-21 | Warner Chilcott Company, Llc | Cyclization process step in the making of quinolones and naphthyridines |
| KR100735587B1 (ko) | 2002-08-05 | 2007-07-04 | 더 프록터 앤드 갬블 캄파니 | 퀴놀론계 항생제 중간체의 제조 방법 |
| US6803469B2 (en) * | 2002-08-05 | 2004-10-12 | The Procter & Gamble Company | Process for preparing quinolone antibiotic intermediates |
| ES2255871B1 (es) * | 2004-12-31 | 2007-08-16 | Quimica Sintetica, S.A. | Procedimiento para la obtencion de levofloxacino exento de sales. |
| US8067402B2 (en) | 2005-12-12 | 2011-11-29 | Allaccem, Inc. | Methods and systems for coating an oral surface |
| CN101020647B (zh) * | 2007-02-14 | 2011-03-30 | 杭州师范学院 | 一种β-环丙胺基丙烯酸(酯)的合成方法 |
| WO2008103847A2 (en) | 2007-02-21 | 2008-08-28 | Allaccem, Incorporated | Bridged polycyclic compound based compositions for the inhibition and amelioration of disease |
| US20080300258A1 (en) * | 2007-05-30 | 2008-12-04 | Souza Fabio Eduardo Silva | Anhydrous ciprofloxacin hydrochloride |
| US8153618B2 (en) | 2007-08-10 | 2012-04-10 | Allaccem, Inc. | Bridged polycyclic compound based compositions for topical applications for pets |
| US8153617B2 (en) | 2007-08-10 | 2012-04-10 | Allaccem, Inc. | Bridged polycyclic compound based compositions for coating oral surfaces in humans |
| US8188068B2 (en) | 2007-08-10 | 2012-05-29 | Allaccem, Inc. | Bridged polycyclic compound based compositions for coating oral surfaces in pets |
| CN105566217B (zh) * | 2016-02-23 | 2019-03-01 | 青岛科技大学 | 一种氟罗沙星粗品的纯化方法 |
| CN111032622A (zh) * | 2017-06-12 | 2020-04-17 | 弗吉尼亚联邦大学 | 流线型合成氟喹诺酮类 |
| CN112552260B (zh) * | 2019-09-26 | 2024-11-08 | 宜昌东阳光长江药业股份有限公司 | 左氧氟沙星及其中间体的制备方法 |
| CN112552261B (zh) * | 2019-09-26 | 2024-11-08 | 宜昌东阳光长江药业股份有限公司 | 左氧氟沙星及其中间体的制备方法 |
| US11884658B1 (en) * | 2023-09-26 | 2024-01-30 | King Faisal University | 1-cyclopropyl-6-fluoro-4-oxo-7-(4-((2-thioxobenzo[d]thiazol-3(2H)-yl)methyl)piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid as an antimicrobial compound |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE279886C (no) * | ||||
| US4383946A (en) * | 1980-03-27 | 1983-05-17 | Merck & Co., Inc. | Process for the preparation of 1-carbapenems and intermediates via silyl-substituted dithioacetals |
| NL8005041A (nl) * | 1980-09-05 | 1982-04-01 | Gist Brocades Nv | Werkwijze voor de bereiding van thioethers, alsmede gesilyleerde thiolen voor toepassing bij deze werkwijze. |
| US4546176A (en) * | 1982-12-14 | 1985-10-08 | Eisai Co., Ltd. | 7-Carboxymethoxyphenylacetamido-3-cephem derivatives and antibacterial preparations containing the same |
| EP0181521A1 (en) * | 1984-10-19 | 1986-05-21 | Otsuka Pharmaceutical Co., Ltd. | Antimicrobial 1-substituted Phenyl-4-oxoquinoline-3-carboxylic acid compounds |
| US4755513A (en) * | 1985-01-30 | 1988-07-05 | Otsuka Pharmaceutical Company, Limited | Antimicrobial 1-substituted phenyl-4-oxoquinoline-3-carboxylic acid compounds |
| DE3509769A1 (de) * | 1985-03-19 | 1986-09-25 | Bayer Ag, 5090 Leverkusen | Verfahren zur herstellung von carbapenemzwischenprodukten |
| US4684648A (en) * | 1985-05-10 | 1987-08-04 | Otsuka Pharmaceutical Company Limited | Antimicrobial 1-substituted phenyl-4-oxoquinoline-3-carboxylic acid compounds and compositions thereof |
| DE3542644A1 (de) * | 1985-12-03 | 1987-06-04 | Hoechst Ag | Verfahren zur herstellung von cefodizim |
| JPS62215591A (ja) * | 1986-03-14 | 1987-09-22 | Dainippon Pharmaceut Co Ltd | ピリドベンズオキサジン誘導体の製造法およびその中間体 |
| EP0242789A3 (en) * | 1986-04-25 | 1990-09-05 | Dainippon Pharmaceutical Co., Ltd. | Novel quinoline derivates and processes for preparation thereof |
| DE3724466A1 (de) * | 1987-07-24 | 1989-02-02 | Bayer Ag | Verfahren zur herstellung von chinoloncarbonsaeuren |
| US4833270A (en) * | 1987-12-21 | 1989-05-23 | American Cyanamid Company | Process for preparing 2-chloro-4,5-difluorobenzoic acid |
| US4920120A (en) * | 1988-01-25 | 1990-04-24 | Warner-Lambert Company | Antibacterial agents |
| EP0342849A3 (en) * | 1988-05-19 | 1990-03-14 | Pfizer Inc. | Intermediates for preparing 1,4-dihydro-4-oxo-quinoline-3-carboxylic acid esters |
| EP0366193A3 (en) * | 1988-10-24 | 1992-01-08 | Norwich Eaton Pharmaceuticals, Inc. | Novel antimicrobial quinolonyl lactams |
| EP0366641B1 (en) * | 1988-10-24 | 2000-07-05 | Norwich Eaton Pharmaceuticals, Inc. | Novel antimicrobial quinolonyl lactam esters |
| ES2014560A6 (es) * | 1988-12-30 | 1990-07-16 | Marga Investigacion | Proceso para la preparacion de un nuevo reactivo organo-sililpolifosforico y su aplicacion al proceso de sontesis de 3-carboxi-quinolonas o azaquinolonas y sus sales. |
| ZA912279B (en) * | 1990-04-09 | 1992-02-26 | Hoffmann La Roche | Carbapenem compounds |
| KR920004385A (ko) * | 1990-08-09 | 1992-03-27 | 와꾸나가 기스께 | 신규 삼환화합물 또는 그의 염, 이의 제조방법 및 이를 함유하는 항균제 |
| IT1248011B (it) * | 1991-06-07 | 1995-01-05 | Mediolanum Farmaceutici Spa | Procedimento per la preparazione dell'acido 9-fluoro-10- (4-metil-1-piperazinil)-7-oxo-2,3-diidro-7h-pirido (1,2,3-de) (1,4)benzotiadin-6-carbossilico cloridrato. |
| BR9206590A (pt) * | 1991-10-01 | 1995-04-25 | Procter & Gamble Pharma | Processo para a obtenção de quinolonil lactamas antimicrobianas |
| EG20543A (en) * | 1992-10-30 | 1999-07-31 | Procter & Gamble | Process for preparing of novel antimicrobial -5- (n-heterosubstituted amino) quinolones |
-
1995
- 1995-08-01 EP EP95927541A patent/EP0775114B1/en not_active Expired - Lifetime
- 1995-08-01 BR BR9508514A patent/BR9508514A/pt not_active Application Discontinuation
- 1995-08-01 MX MX9700871A patent/MX9700871A/es unknown
- 1995-08-01 WO PCT/US1995/009647 patent/WO1996004247A1/en not_active Ceased
- 1995-08-01 JP JP8506673A patent/JPH10504815A/ja active Pending
- 1995-08-01 DK DK95927541T patent/DK0775114T3/da active
- 1995-08-01 KR KR1019970700703A patent/KR100242355B1/ko not_active Expired - Fee Related
- 1995-08-01 CA CA002196538A patent/CA2196538C/en not_active Expired - Fee Related
- 1995-08-01 DE DE69515882T patent/DE69515882T2/de not_active Expired - Fee Related
- 1995-08-01 AU AU31539/95A patent/AU705818B2/en not_active Ceased
- 1995-08-01 ES ES95927541T patent/ES2143644T3/es not_active Expired - Lifetime
- 1995-08-01 CN CN95195124A patent/CN1158120A/zh active Pending
- 1995-08-01 AT AT95927541T patent/ATE190972T1/de not_active IP Right Cessation
- 1995-08-01 FI FI970427A patent/FI970427A7/fi unknown
- 1995-08-01 NZ NZ290721A patent/NZ290721A/xx unknown
- 1995-08-01 PT PT95927541T patent/PT775114E/pt unknown
-
1996
- 1996-11-14 US US08/749,046 patent/US5703231A/en not_active Expired - Fee Related
-
1997
- 1997-01-31 NO NO19970427A patent/NO311356B1/no not_active IP Right Cessation
-
2000
- 2000-03-23 GR GR20000400607T patent/GR3033001T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| FI970427L (fi) | 1997-03-26 |
| US5703231A (en) | 1997-12-30 |
| FI970427A7 (fi) | 1997-03-26 |
| NO311356B1 (no) | 2001-11-19 |
| BR9508514A (pt) | 1997-12-23 |
| DE69515882T2 (de) | 2000-11-02 |
| KR970704694A (ko) | 1997-09-06 |
| EP0775114B1 (en) | 2000-03-22 |
| KR100242355B1 (ko) | 2000-03-02 |
| NZ290721A (en) | 1999-03-29 |
| AU3153995A (en) | 1996-03-04 |
| EP0775114A1 (en) | 1997-05-28 |
| CN1158120A (zh) | 1997-08-27 |
| MX9700871A (es) | 1997-05-31 |
| CA2196538A1 (en) | 1996-02-15 |
| AU705818B2 (en) | 1999-06-03 |
| PT775114E (pt) | 2000-09-29 |
| NO970427D0 (no) | 1997-01-31 |
| ATE190972T1 (de) | 2000-04-15 |
| CA2196538C (en) | 2000-04-25 |
| DE69515882D1 (de) | 2000-04-27 |
| WO1996004247A1 (en) | 1996-02-15 |
| DK0775114T3 (da) | 2000-07-10 |
| ES2143644T3 (es) | 2000-05-16 |
| FI970427A0 (fi) | 1997-01-31 |
| GR3033001T3 (en) | 2000-07-31 |
| JPH10504815A (ja) | 1998-05-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO970427L (no) | Fremgangsmåte for fremstilling av antimikrobielle forbindelser | |
| AU679859B2 (en) | Novel compound, process for producing the same, and antitumor agent | |
| ES8300112A1 (es) | Un procedimiento para preparar compuestos de cefem . | |
| FI942881A0 (fi) | 2-piperatsinoniyhdisteet ja niiden käyttö | |
| ATE181066T1 (de) | Zwischenverbindungen zur herstellung von thioalkylthio cephalosporinderivaten | |
| DK44682A (da) | Fremgangsmaade til fremstilling af substituerede imidazolderivater | |
| NZ503822A (en) | 2-halo-6-O-substituted erythromycin derivatives, a process for their preparation and pharmaceuticals thereof, useful for treating bacterial infections | |
| CA2226406A1 (en) | Novel pyridone carboxylic acid derivatives | |
| IE811580L (en) | Herbicidal compounds | |
| DK0548338T3 (da) | Fremgangsmåde til fremstilling af cephalosporinmellemprodukter | |
| ES8706144A1 (es) | Un procedimiento para preparar derivados de 1,8-naftiridina | |
| CA2168563A1 (en) | Benzopyrans and Pharmaceutical Compositions Containing Them | |
| CA2221946A1 (en) | Production process of cyclic compound | |
| IE801440L (en) | Insecticidally active acyl-ureas. | |
| GB2334032A (en) | Bis(acridinecarboxamide) and bis(phenazinecarboxamide) as antitumour agents | |
| TR199901301T2 (xx) | Yeni eritromisin t�revleri ve bunlar�n haz�rlanma y�ntemi. | |
| CA2308315A1 (en) | N,n'-bis(sulfonyl)hydrazines useful as antineoplastic agents | |
| DE3787030D1 (de) | 1-carboxy-1-vinyloxyiminoaminothiazol-cephalosporin-derivate und deren herstellung. | |
| CA1268183A (en) | INTERMEDIATES OF PHOSPHORANE USED IN THE PREPARATION OF ANTIBIOTIC PENEMS | |
| ES8304973A1 (es) | Un procedimiento para la preparacion de nuevos derivados de tiocarbapenem 3-sustituidos. | |
| ES2144446T3 (es) | Compuestos de carbapenem antibioticos. | |
| KR970042501A (ko) | 새로운 아민고리 화합물 | |
| SE8405338D0 (sv) | (1,3) oxazino (4,3-a) isoquinoline derivatives, process for their preparation and pharmaceutical compositions containing them | |
| NO872006D0 (no) | Fremgangsmaate for fremstilling av cefalosporinderivater. | |
| KR960017657A (ko) | 신규 퀴놀린카르복실산 유도체 및 그 제조방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |
Free format text: LAPSED IN FEBRUARY 2003 |